EUCARE Co., Ltd.

NA

EUCRASIA

EUCRASIA contributes to the development of various communities and individuals in the healthcare and co-medical fields, by designing and embodying the harmony of the components of health in modern society through the latest ICT and theories. In January 2021, we were established as a new strategic subsidiary of the BOW Holdings Group to play a central role in the healthcare business. We will contribute to society through the use of data as an innovative player leading technological innovation in the healthcare and co-medical fields at home and abroad.

EVER FORTUNE.AI CO., LTD.

EverFortune.AI provides 3 categories of product:
Medical AI suites, Cloud Medical Platforms and Medical Big Data.
We believe our Holistic Healthcare AI Solutions Bring Better Medical Outcomes.
1. EFAI Solutions and Products
2. EFAI FDA Clearance Systems
3. EFAI RT Suite CT HCAP-Segmentation System

Ever Supreme Bio Technology Co., LTD

UMSC01 is the first drug in Taiwan to receive approval for a New Drug Application from the U.S. FDA and the go-ahead from the Taiwan FDA for clinical trials. This breakthrough treatment for multiple sclerosis is now undergoing Phase I and IIa clinical trials in Taiwan. Starting in September 2023, we have initiated SIV for patient enrollment. This year, we showcased UMSC01 at the BIO International Convention and the Japan Bioindustry Association Expo, drawing attention from numerous global companies. Get to know Ever Supreme and our pioneering efforts in medical innovation.

Ever Supreme Bio Technology Co.,Ltd.

Ever Supremes’ commitment to leading on world\\\'s top cell therapy research and development groups to improve the health of the world and enhance the quality of medical treatment and life. Ever Supreme has a number of innovative and breakthrough patents and technologies, and has gathered a number of research and development teams and consultants with professional doctoral and master\\\'s in medical backgrounds in Taiwan and oversea. Ever Supreme is committed to the research and development on new drugs for stem cells and cancer immune cells, and take challenges on resolving bottlenecks of existing medical treatment, and offer innovative, effective personalized precision medical services. Ever Supreme is looking forward to the future by becoming the driven force behind Taiwan’s biotechnology and medical industry, as well as an advanced cell pharmaceutical company in the Asia-Pacific region. Also, by collaborating the world’s top peers to move towards a new era for precision personalized medicine and carry out the spirit of company mottos—\\

ExoOne Bio Co. Ltd.

ExoOne Bio is the first biotech company specializing in exosome research and development for new drug therapies in Taiwan. The high-quality exosomes produced by ExoOne Bio are currently applied in the development of three key areas:

1.High-quality exosome raw materials: available for laboratory or industrial development and research.
2.New drug development: ExoOne focuses on therapies for degenerative diseases.
3.Exosome-based cosmetics and hair care products.

ExoOne Bio has a professional scientific research team utilizing cutting-edge biotechnology and strict production standards. They have developed a series of highly acclaimed products, including the Rejuvenation Ampule, Flawless Essence, Princess Mask, and ExoHair Essence.